Market Overview:
The global NGS reagent kit market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for personalized medicine, rising prevalence of cancer and other diseases, and technological advancements in NGS platforms. Based on type, the global NGS reagent kit market can be segmented into blood test, saliva test, urine test, and other tests. The blood test segment is expected to account for the largest share of the global NGS reagent kit market in 2018. This segment is projected to grow at a CAGR of 11% during the forecast period from 2018 to 2030. This growth can be attributed to factors such as growing demand for non-invasive diagnostic tests and increasing incidence of cancer worldwide. Based on application, the global NGS reagent kit market can be divided into hospital laboratories, clinic laboratories, research laboratories/academic institutions (non-profit), contract research organizations (CROs), biotechnology & pharmaceutical companies (BPOs), and others segments including point-of-care testing (POCT) locations such as clinics & hospitals). The hospital laboratory segment is expected to account for the largest share of the global NGS reagent kit market in 2018 followed by clinic laboratories segments respectively .
Product Definition:
NGS Reagent Kit is a set of enzymes, buffers, and other chemicals used in the preparation of DNA or RNA samples for Next-Generation Sequencing. The kit is important for researchers because it allows them to sequence DNA or RNA accurately and efficiently.
Blood Test:
Blood test is used for detecting the presence of disease-causing pathogens in the blood. It's a quick and easy method to diagnose several infectious diseases, including HIV, hepatitis B & C, and syphilis. The tests are performed on dried blood spot samples from a patient’s finger or toe.
Saliva Test:
Saliva test is a quick and easy method used for detecting the presence of nucleic acid in oral fluids. It works by amplification of DNA or RNA from the sample with the help of specialized enzymes present in saliva. This process is commonly used for testing whether an individual has consumed drugs or alcohol, which are considered to be carcinogenic.
Application Insights:
Clinical application of NGS is witnessing significant growth owing to its ability to detect genetic abnormalities with high specificity and sensitivity. The growing adoption of NGS in clinical research activities across various applications such as drug discovery & development, cancer diagnostics, and biomarker discovery is expected to drive the market over the forecast period.
The other segment includes research applications such as structural variation analysis, exome sequencing for protein-protein interaction studies, identification of novel disease genes/causes and gene expression analysis. Growing government funding for genomics-based research coupled with rising R&D investments by companies are anticipated to augment the segment growth during the study period.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This can be attributed to the presence of key players, increased adoption rate of advanced technologies and high disease prevalence levels. Moreover, increasing government funding for research activities is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as rising disposable income and growing target population base especially in countries such as China & India.
Growth Factors:
- Increasing demand for personalized medicine
- Growing number of cancer patients
- Rising prevalence of target diseases
- Technological advancements in NGS platforms and reagents kits
- Increasing R&D investments in the life sciences sector
Scope Of The Report
Report Attributes
Report Details
Report Title
NGS Reagent Kit Market Research Report
By Type
Blood Test, Saliva Test, Urine Test, Other
By Application
Hospital, Clinic, Laborary, Other
By Companies
Illumina, Omega Bio-tek, RTA Laboratories, QuantaBio, ZINEXTS, Ampliqon A/S, Bioneer Corporation, Loop Genomics, NimaGen B.V., Swift Biosciences, Lexogen, Bioneer Corporation, Covaris Inc, Dovetail Genomics, Menarini Silicon Biosystems, PCR Biosystems Ltd., Nippon Genetics, QIAGEN, TAKARA, Zymo Research, Verogen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global NGS Reagent Kit Market Report Segments:
The global NGS Reagent Kit market is segmented on the basis of:
Types
Blood Test, Saliva Test, Urine Test, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Laborary, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina
- Omega Bio-tek
- RTA Laboratories
- QuantaBio
- ZINEXTS
- Ampliqon A/S
- Bioneer Corporation
- Loop Genomics
- NimaGen B.V.
- Swift Biosciences
- Lexogen
- Bioneer Corporation
- Covaris Inc
- Dovetail Genomics
- Menarini Silicon Biosystems
- PCR Biosystems Ltd.
- Nippon Genetics
- QIAGEN
- TAKARA
- Zymo Research
- Verogen
Highlights of The NGS Reagent Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Test
- Saliva Test
- Urine Test
- Other
- By Application:
- Hospital
- Clinic
- Laborary
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NGS Reagent Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NGS Reagent Kit is a collection of reagents used for sequencing DNA and RNA.
Some of the key players operating in the ngs reagent kit market are Illumina, Omega Bio-tek, RTA Laboratories, QuantaBio, ZINEXTS, Ampliqon A/S, Bioneer Corporation, Loop Genomics, NimaGen B.V., Swift Biosciences, Lexogen, Bioneer Corporation, Covaris Inc, Dovetail Genomics, Menarini Silicon Biosystems, PCR Biosystems Ltd., Nippon Genetics, QIAGEN, TAKARA, Zymo Research, Verogen.
The ngs reagent kit market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 NGS Reagent Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 NGS Reagent Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 NGS Reagent Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the NGS Reagent Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global NGS Reagent Kit Market Size & Forecast, 2020-2028
4.5.1 NGS Reagent Kit Market Size and Y-o-Y Growth
4.5.2 NGS Reagent Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Blood Test
5.2.2 Saliva Test
5.2.3 Urine Test
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Laborary
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global NGS Reagent Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 NGS Reagent Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Blood Test
9.6.2 Saliva Test
9.6.3 Urine Test
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Laborary
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Blood Test
10.6.2 Saliva Test
10.6.3 Urine Test
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Laborary
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Blood Test
11.6.2 Saliva Test
11.6.3 Urine Test
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Laborary
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Blood Test
12.6.2 Saliva Test
12.6.3 Urine Test
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Laborary
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Blood Test
13.6.2 Saliva Test
13.6.3 Urine Test
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Laborary
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 NGS Reagent Kit Market: Competitive Dashboard
14.2 Global NGS Reagent Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina
14.3.2 Omega Bio-tek
14.3.3 RTA Laboratories
14.3.4 QuantaBio
14.3.5 ZINEXTS
14.3.6 Ampliqon A/S
14.3.7 Bioneer Corporation
14.3.8 Loop Genomics
14.3.9 NimaGen B.V.
14.3.10 Swift Biosciences
14.3.11 Lexogen
14.3.12 Bioneer Corporation
14.3.13 Covaris Inc
14.3.14 Dovetail Genomics
14.3.15 Menarini Silicon Biosystems
14.3.16 PCR Biosystems Ltd.
14.3.17 Nippon Genetics
14.3.18 QIAGEN
14.3.19 TAKARA
14.3.20 Zymo Research
14.3.21 Verogen
